Deferasirox NOBEL 90 mg

Deferasirox NOBEL 90 mg is a medicine authorised by Swissmedic under authorisation number 67681. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 August 2020 and the authorisation is valid without a time limit. ATC code V03AC03 places the medicine in the group All other therapeutic products.

  • Dispensing category B
  • Authorisation number 67681
  • ATC V03AC03
  • Synthetic medicines
Authorisation data
Authorisation number67681
NameDeferasirox NOBEL 90 mg
Full nameDeferasirox NOBEL 90 mg, Filmtabletten
Authorisation holderNOBEL Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeV03AC03
First authorisation24 August 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Deferasirox NOBEL 90 mg, FilmtablettenB24 August 2020
2Deferasirox NOBEL 180 mg, FilmtablettenB24 August 2020
3Deferasirox NOBEL 360 mg, FilmtablettenB24 August 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)V03AC0306.99.0.B
290Tablette(n)V03AC0306.99.0.B
330Tablette(n)V03AC0306.99.0.B
490Tablette(n)V03AC0306.99.0.B
530Tablette(n)V03AC0306.99.0.B
690Tablette(n)V03AC0306.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Deferasirox NOBEL 90 mg authorised in Switzerland?

Yes. Deferasirox NOBEL 90 mg is authorised by Swissmedic under authorisation number 67681, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Deferasirox NOBEL 90 mg have?

Deferasirox NOBEL 90 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Deferasirox NOBEL 90 mg?

The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com